The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit.
Villegas-Esguevillas M, Cho S, Vera-Zambrano A, Kwon JW, Barreira B, Telli G, Navarro-Dorado J, Morales-Cano D, de Olaiz B, Moreno L, Greenwood I, Pérez-Vizcaíno F, Kim SJ, Climent B, Cogolludo A.
Villegas-Esguevillas M, et al. Among authors: climent b.
Biomed Pharmacother. 2023 Aug;164:114952. doi: 10.1016/j.biopha.2023.114952. Epub 2023 Jun 7.
Biomed Pharmacother. 2023.
PMID: 37295249
Free article.